Srinivas Akkaraju Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days ago
Srinivas Akkaraju has an estimated net worth of at least $226.3 million*, as of Feb. 19, 2025. They own 5.6 million shares of SRRK stock. They have sold 1.2 million shares of SRRK stock since 2021, for an estimated $19.4 million.
Srinivas Akkaraju $SRRK SEC Form 4 Insider Trading
Srinivas Akkaraju has filed a total of 4 insider trades in $SRRK since 2021. Their most recent trade was a sale of 510,000 shares, made on Oct 07, 2024. Their largest trade was a purchase of 2.2 million shares, made on Oct 16, 2023. We estimate that they now own 5.6 million shares of $SRRK, worth an estimated $206.9 million.
Insider Trading at $SRRK
There have been a total of 81 insider trades reported at $SRRK since 2021, with 8.1 million shares purchased and 4.0 million shares sold. The most active insider traders in $SRRK stock have been Edward H Myles, Jing L. Marantz, and Mo Qatanani. The most recent trade was a sale of 4,135 shares reported by Mo Qatanani (CHIEF SCIENTIFIC OFFICER), made on Feb 18, 2025.
History of Insider Stock Trades by Srinivas Akkaraju
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
SRRK
|
Sale | 510,000 | Oct 07, 2024 | Oct. 7, 2024, 8:55 p.m. |
|
SRRK
|
Sale | 510,000 | Oct 07, 2024 | Oct. 7, 2024, 8:55 p.m. |
|
SRRK
|
Sale | 155,713 | Oct 07, 2024 | Oct. 7, 2024, 8:55 p.m. |
SYRS
|
Purchase | 904,977 | Dec 21, 2023 | Dec. 26, 2023, 6:24 p.m. |
|
SRRK
|
Purchase | 2.2 million | Oct 16, 2023 | Oct. 18, 2023, 5:46 p.m. |
MLYS
|
Purchase | 937,500 | Feb 14, 2023 | Feb. 16, 2023, 5:54 p.m. |
KDNY
|
Purchase | 570,000 | May 27, 2022 | June 1, 2022, 4:13 p.m. |
|
KDNY
|
Purchase | 1.2 million | Nov 15, 2021 | Nov. 17, 2021, 1:05 p.m. |
|
KDNY
|
Purchase | 208,500 | Aug 18, 2021 | Aug. 19, 2021, 8 p.m. |
GRPH
|
Purchase | 485,000 | Jun 29, 2021 | June 30, 2021, 8 p.m. |
|
GRPH
|
Purchase | 15,000 | Jun 29, 2021 | June 30, 2021, 8 p.m. |
$SRRK Executives and Stock Owners with Insider Trades
-
Edward H Myles, COO & CFO
-
Jing L. Marantz, CHIEF MEDICAL OFFICER
-
Mo Qatanani, CHIEF SCIENTIFIC OFFICER
-
Caryn Parlavecchio, CHRO
-
Junlin Ho, GENERAL COUNSEL
-
Edward H Myles, Chief Financial Officer
-
Jay T. Backstrom, CHIEF EXECUTIVE OFFICER
-
Mo Qatanani, SVP AND HEAD OF RESEARCH
-
Tracey Sacco, CHIEF COMMERCIAL OFFICER
-
Tracey Sacco, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.